Free shipping on all orders over $ 500

 About 1 result found for searched term "1847461-43-1" (0.12 seconds)

Cat.No.  Name Target
M9535 Mobocertinib EGFR/HER2
TAK-788; AP32788
Mobocertinib (TAK-788) is an investigational TKI with potent, selective preclinical activity against activating EGFR and HER2 mutations, including exon 20 insertions.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.